Sudeh Izadmehr, Heriberto Fernandez-Hernandez, Danica Wiredja, Alexander Kirschenbaum, Christine Lee-Poturalski, Peyman Tavassoli, Shen Yao, Daniela Schlatzer, Divya Hoon, Analisa Difeo, Alice C Levine, Juan-Miguel Mosquera, Matthew D Galsky, Carlos Cordon-Cardo, Goutham Narla
Metastasis remains a major cause of morbidity and mortality in men with prostate cancer, and the functional impact of the genetic alterations, alone or in combination, driving metastatic disease remains incompletely understood. The proto-oncogene c-MYC, commonly deregulated in prostate cancer. Transgenic expression of c-MYC is sufficient to drive the progression to prostatic intraepithelial neoplasia and ultimately to moderately differentiated localized primary tumors, however, c-MYC-driven tumors are unable to progress through the metastatic cascade, suggesting that a "second-hit" is necessary in the milieu of aberrant c-MYC-driven signaling...
February 1, 2024: bioRxiv